Saxenda® and Victoza® provide the exact active component, liraglutide, and should not be used alongside one another or with other GLP-1 receptor agonist medicinesthat are pregnant. Weight loss presents no probable reward to the Expecting woman and should cause fetal harm. A least weight attain, and no weight loss, is at the moment encouraged fo